MAINZ BIOMED B V's ticker is and the CUSIP is N5436L101. A total of 7 filers reported holding MAINZ BIOMED B V in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenwich Investment Management, Inc. | 14,159 | $67,000 | 0.05% |
| UBS Group AG | 931 | $4,450 | 0.00% |
| NewEdge Advisors, LLC | 1,000 | $4,780 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $478 | 0.00% |
| WELLS FARGO & COMPANY/MN | 500 | $2,390 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 673 | $3,217 | 0.00% |
| MORGAN STANLEY | 200 | $956 | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,500 | $7,170 | 0.00% |
| JPMORGAN CHASE & CO | 14 | $67 | 0.00% |